MC
HNGE

Moors & Cabot’s Hinge Health HNGE Stock Holding History

Moors & Cabot’s Portfolio HNGE Stock Details HNGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-4,875
Closed -$226K – 991
2025
Q4 		$226K Buy
+4,875
New +$235K 0.01% 813

Other funds holding HNGE

IHG
Insight Holdings Group New York $1.42B AUM 41.03% 1-Year Est. Return
12CM
11.2 Capital Management Las Vegas, Nevada $143M AUM
DMC
Deer Management Company Larchmont, New York $622M AUM 24.27% 1-Year Est. Return
BC
BIT Capital Berlin, Germany $2.07B AUM 157.17% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Moors & Cabot's HNGE Position: Q1 2026 in Review

Moors & Cabot sold out of Hinge Health (HNGE) in Q1 2026, closing a stake of 4,875 shares — an estimated $226K sold.

Moors & Cabot first reported a position in HNGE in Q4 2025 and held it in 1 quarter. The position peaked at $226K in Q4 2025. 203 funds tracked by Wall St. Rank hold HNGE as of Q1 2026.

  • Moors & Cabot reported no remaining Hinge Health position as of Q1 2026 after selling out during the quarter.
  • Moors & Cabot sold 4,875 Hinge Health shares in Q1 2026, an estimated $226K.
  • Moors & Cabot first reported a position in Hinge Health in Q4 2025 and held it in 1 quarter.
  • Moors & Cabot's Hinge Health position peaked at $226K in Q4 2025.
  • 203 funds tracked by Wall St. Rank held Hinge Health as of Q1 2026.

Based on Moors & Cabot's 13F filing for Q1 2026, filed 8 May 2026.